These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20070889)

  • 1. Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study.
    Curioso WH; Kepka D; Cabello R; Segura P; Kurth AE
    BMC Public Health; 2010 Jan; 10():13. PubMed ID: 20070889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.
    Shrestha A; Poudel L; Shrestha S; Jha N; Kuikel BS; Shakya P; Kunwar RS; Pandey LR; Kc MB; Wilson EC; Deuba K
    BMC Health Serv Res; 2024 Aug; 24(1):927. PubMed ID: 39138448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.
    Musumari PM; Feldman MD; Techasrivichien T; Wouters E; Ono-Kihara M; Kihara M
    AIDS Care; 2013; 25(10):1271-7. PubMed ID: 23383757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I want to be healthy and move on": A qualitative study of barriers and facilitators to antiretroviral treatment adherence among young adult survivors with perinatal HIV in Thailand.
    Aurpibul L; Tangmunkongvorakul A; Detsakunathiwatchara C; Srita A; Masurin S; Meeart P; Chueakong W
    PLoS One; 2024; 19(7):e0305918. PubMed ID: 39012925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mixed Methods Study of Anticipated and Experienced Stigma in Health Care Settings Among Women Living with HIV in the United States.
    Rice WS; Turan B; Fletcher FE; Nápoles TM; Walcott M; Batchelder A; Kempf MC; Konkle-Parker DJ; Wilson TE; Tien PC; Wingood GM; Neilands TB; Johnson MO; Weiser SD; Turan JM
    AIDS Patient Care STDS; 2019 Apr; 33(4):184-195. PubMed ID: 30932700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study.
    Sanjobo N; Frich JC; Fretheim A
    SAHARA J; 2008 Sep; 5(3):136-43. PubMed ID: 18979047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study.
    Madiba S; Josiah U
    Biomed Res Int; 2019; 2019():9623159. PubMed ID: 31886271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caretakers' barriers to pediatric antiretroviral therapy adherence in Vietnam - A qualitative and quantitative study.
    Tran CT; Pham TH; Tran KT; Nguyen TKC; Larsson M
    Appl Nurs Res; 2017 Jun; 35():1-5. PubMed ID: 28532715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
    Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
    AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.
    Okoror TA; Falade CO; Olorunlana A; Walker EM; Okareh OT
    AIDS Patient Care STDS; 2013 Jan; 27(1):55-64. PubMed ID: 23305262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to and facilitators of adherence to antiretroviral therapy among people living with HIV in Lao PDR: a qualitative study.
    Portelli MS; Tenni B; Kounnavong S; Chanthivilay P
    Asia Pac J Public Health; 2015 Mar; 27(2):NP778-88. PubMed ID: 22535549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective.
    Lyimo RA; de Bruin M; van den Boogaard J; Hospers HJ; van der Ven A; Mushi D
    BMC Public Health; 2012 Aug; 12():716. PubMed ID: 22935331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
    Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
    AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "What if I got rejected by the girl? I would rather stop the pills": barriers and facilitators of adherence to antiretroviral therapy for emerging adults aged 18-29 living with HIV in Zimbabwe.
    Jopling R; Mutsvuke W; Fertig M; O'Cleirigh C; Mangezi W; Abas M
    AIDS Care; 2024 Jul; 36(sup1):168-178. PubMed ID: 38537178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV understanding, experiences and perceptions of HIV-positive men who have sex with men in Amazonian Peru: a qualitative study.
    Tattsbridge J; Wiskin C; de Wildt G; Clavé Llavall A; Ramal-Asayag C
    BMC Public Health; 2020 May; 20(1):728. PubMed ID: 32429863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.
    Croome N; Ahluwalia M; Hughes LD; Abas M
    AIDS; 2017 Apr; 31(7):995-1007. PubMed ID: 28121707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.
    Tabatabai J; Namakhoma I; Tweya H; Phiri S; Schnitzler P; Neuhann F
    Glob Health Action; 2014; 7():24795. PubMed ID: 25280736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.